Skip to Main Content

Paper Details

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling.
Leukemia
67
2018
AKT, BH3, BH3-family protein, JAK, Janus-activated kinase, SNS-032, STAT, T, T-PLL, T-cell prolymphocytic leukemia, cyclin-dependent kinase, gene, heat-shock protein, histone deacetylase, neoplasm of, p53, phosphoinositide-3 kinase, rapamycin, signal transducer
Author NameAffiliation
Suleiman A KhanInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Olli KallioniemiInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Krister WennerbergInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Wolfgang Huber
Wolfgang Huber
Simon AndersInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Simon AndersInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Jing TangInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Jing TangUniversity of Turku
Tero AittokallioInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Tero AittokallioUniversity of Turku
  • 1 - 11

Datasets

Release 1.2